This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Athena Diagnostics, Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Felicita Dubois: Innovator in Clinical Genetics
Introduction
Felicita Dubois is a prominent inventor based in San Juan Capistrano, California. She has made significant contributions to the field of clinical genetics, particularly through her innovative patent that addresses the clinical significance of genetic variants. Her work is vital in enhancing our understanding of genetic conditions and their implications for human health.
Latest Patents
Felicita holds a patent for a "Pathogenicity scoring system for human clinical genetics." This patent outlines methods and systems for determining the clinical significance of a genetic variant. The methods involve calculating various scores, including a function score, frequency score, co-occurrence score, and family segregation score. These scores are aggregated using computer systems to generate a clinical significance score that indicates the relevance of the genetic variant. Felicita has 1 patent to her name.
Career Highlights
Felicita is currently employed at Athena Diagnostics, Inc., where she continues to advance her research in clinical genetics. Her work has been instrumental in developing tools that aid in the assessment of genetic variants, which can lead to better diagnostic and therapeutic strategies for patients.
Collaborations
Felicita collaborates with notable colleagues, including Joseph Higgins and Christina Divincenzo. Their combined expertise contributes to the innovative environment at Athena Diagnostics, fostering advancements in genetic research.
Conclusion
Felicita Dubois is a key figure in the field of clinical genetics, with her innovative patent paving the way for improved understanding and assessment of genetic variants. Her contributions are essential for the future of genetic research and its applications in healthcare.
